Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia.
Martínez-Rivera A, Fetcho RN, Birmingham L, Xu J, Yang R, Foord C, Scala-Chávez D, Mekawy N, Pleil K, Pickel VM, Liston C, Castorena CM, Levitz J, Pan YX, Briand LA, Rajadhyaksha AM, Lee FS.
Martínez-Rivera A, et al. Among authors: yang r.
Sci Adv. 2024 Nov 29;10(48):eadq4779. doi: 10.1126/sciadv.adq4779. Epub 2024 Nov 29.
Sci Adv. 2024.
PMID: 39612328